Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Silver Creek Pharmaceuticals

Request full access

Developing a pipeline of innovative new regenerative medicines to treat a range of serious diseases

South San Francisco, United StatesFounded 2010Biotech & Life Sciences

About Silver Creek Pharmaceuticals

Silver Creek Pharmaceuticals is a research and development-focused company specializing in innovative treatments for acute injuries to well-perfused organs such as the heart, kidney, and brain. The company leverages computational modeling to discover protein engineering design principles that drive apoptosis, or programmed cell death. Silver Creek's competitive advantages include a strong global network through its board of directors, cost-effective in-house studies, and support from Key Opinion Leaders (KOLs). The company aims to bring its drugs through clinical trials and into the market by forming partnerships with global pharmaceutical companies. Silver Creek's primary focus is on developing a Smart Growth Factor (SGF) to aid patients suffering from organ damage due to ischemic events, including acute kidney, heart, and brain injuries. The company operates in the biopharmaceutical market, targeting conditions with high unmet medical needs. Its business model involves early-stage drug development, followed by strategic partnerships for commercialization. Revenue is generated through licensing agreements and milestone payments from partner pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
12
Open positions
None listed
Dealroom signal
37.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Innovation Management, Biotechnology, Cardiology and cardiovascular, Tissue Engineering, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCEquity / VC Feb 2022 $9.2M $37M Undisclosed —
EARLY VC✓Equity / VC Feb 2018 $20M $80M Goldman Sachs · JP Morgan —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Silver Creek Pharmaceuticals website traffic

Latest recorded traffic for Silver Creek Pharmaceuticals is 900 monthly website visits, down 62.5% over the last three months. Silver Creek Pharmaceuticals's team declined 14.3% over the past year.

Latest monthly visits900 3-month web change-62.5% 1-year team growth-14.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Hoba TherapeuticsDeveloper of neuropathic pain and CNS therapies. The company develops biopharmaceuticals for chronic pain and hearing loss Copenhagen, Denmark Operational 5 $28M $101M
SyntheXTargeting the undruggable with synthetic biology-based drug discovery platforms San Francisco, United States Operational
3P BiopharmaceuticalsCMO, biotech, protein manufacturing, microbial fermentation, mammalian, cell banking, contract manufacturing, biopharmaceuticals, cGMP, GMP Noáin (Valle de Elorz)/Noain (Elortzibar), Spain Acquired
CollplantRegenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing Ness Ziona, Israel Operational
Interline TherapeuticsLeveraging advances in genomics, proteomics, and computational chemistry to identify new medicines San Francisco, United States Operational
KbDNALab provider, introducing specialty bio-research material and tools, supporting experimental design; via a custom ecommerce platform Braintree, United States Operational
FitgenesAustralian organization that delivers personalized, genome-based health and wellness programs Brisbane, Australia Operational
QurAlisBiotech company focused on developing precision solutions to cure amyotrophic lateral sclerosis Cambridge, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Silver Creek Pharmaceuticals in the South San Francisco ecosystem

Live from Dealroom

The Silver Creek Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Other known investors1 additional known investor

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States85.7%
🇬🇧 United Kingdom14.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Silver Creek Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Silver Creek Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.